Where does Axion Biosystems, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Axion Biosystems, Inc. ranks #19,485 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Axion Biosystems, Inc. hold?

Axion Biosystems, Inc. holds 14 US utility patents granted between 2016 and 2025, spanning 7 technology areas.

What is Axion Biosystems, Inc.'s Innovation Score?

Axion Biosystems, Inc. has an Innovation Score of 32.5 out of 100 (42nd percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Axion Biosystems, Inc. focus on?

Axion Biosystems, Inc.'s top technology area is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties) with 11 patents, ranking #1,329 of 7,863 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

Is Axion Biosystems, Inc.'s patent grant rate increasing or decreasing?

Axion Biosystems, Inc.'s recent grant velocity is -82% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Axion Biosystems, Inc.'s patents?

Axion Biosystems, Inc.'s patents average 23.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Axion Biosystems, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Axion Biosystems, Inc.

USPTO PatentsView assignee record - 14 granted patents across 7 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Axion ranks #19,485 of 49,997 tracked US assignees by granted-patent volume, with 14 patents across 7 technology areas.

#19,485
of 49,997 US assignees by volume: 42nd percentile
by Innovation Score (32.5/100): 23.1
avg claims per patent: -82%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R19485 · US Corporation #19,485 · 14 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-DENSE · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 14 grants
MID-PACK #19,485/49,997
PHOTO-FINISH Aatru Medical
CPC-NARROW G01N · 7 areas
INNOV-THIN 32.5/100
CLAIMS-DENSE 23.1 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -82% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Aatru Medical, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Axion’s 32.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.4 pts (29%) Velocity 0.0 pts (0%) Breadth 9.4 pts (29%) Claim depth 13.8 pts (42%)

Qualcomm Incorporated · highest

85
Axion Biosystems · this assignee

33
3D Lighting… · lowest

7

What this shows Axion's Innovation Score is 32.5/100 (42nd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Axion?

Each dot is one of Axion’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Axion’s own 23.1 claims/patent is ABOVE the 13.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Axion vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Axion's grants concentrate

Axion Biosystems, Inc. is a focused PatentsView assignee: 7 CPC subclasses with 78.6% of grants classified under G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties). Peak complete grant year is 2016 (5 grants) versus a trough of 1 in 2017. By volume, Axion sits between Avista Pharma Solutions, Inc. and Acacia Pharma Limited.

Avista Pharma Sol…

14
AVL Emissions Tes…

14
AVO Multi-amp

14
Axia Acquisition

14
Aatru Medical

14
Aavid Thermalloy

14
Abominable Labs

14
Acacia Pharma

14
Axion Biosystems ◀

14

What this shows Axion holds 14 patents at rank #19,442, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Axion

By rank, the assignees closest to #19,442 in granted patent volume.

Leaders in G01N (Investigating OR Analysing Materials BY Determining Their…)

Other assignees with the most granted patents in Axion's primary technology class.

Axion's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

33 42nd percentile higher than 42% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table

Axion Biosystems, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2016	5	35.7%
2017	1	7.1%
2018	3	21.4%
2019	2	14.3%
2021	2	14.3%
2025partial year	1	7.1%

Which technologies does Axion Biosystems, Inc. patent most?

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 11

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 7

A61B - DIAGNOSIS; SURGERY; Identification 4

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 4

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 2

H04L - Transmission OF Digital Information, e.g. Telegraphic Communication 2

H05K - Printed CIRCUITS; Casings OR Constructional Details OF Electric APPARATUS; Manufacture OF Assemblages OF Electrical Components 1

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Axion Biosystems, Inc.'s patent record in context - here's where to go next.

Axion Biosystems, Inc.'s lead technology class is G01N (Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties), 78.6% of its portfolio - see every assignee active in that class. Explore G01N
Ranked #19,485 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Axion Biosystems, Inc. against Avista Pharma Solutions, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 32.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.